ArticleThe Pan African medical journal2024
The Daily Mile reduces depressive and anxiety symptoms in school-going Ugandan adolescents aged 16-17.
Article in The Pan African medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: school-based physical activity (PA) programs such as The Daily Mile (TDM) might be vital in the prevention and treatment of mental health problems in adolescents in low-income countries. The aim of this single-arm non-controlled pilot intervention study was to investigate TDM on symptoms of anxiety and depression in adolescents aged 16-17 years in Uganda. Methods: The Daily Mile (TDM) took place between February and April 2022. In total 177 adolescents (62.7% girls) completed the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 Questionnaire (GAD-7) pre and post-12 weeks TDM. Results: moderate effect sizes were found for reductions in PHQ-9 (Cohen´s d=-68, 95% CI=-0.84 to -0.52, P<0.001) and GAD-7 (Cohen´s d=-0.54, 95%CI=-0.68 to -0.38, P<0.001) following TDM. In those with at least mild symptoms, large effect sizes were observed for reductions in PHQ-9 (Cohen´s d=-0.94, 95%CI=-1.14 to -0.72, P<0.001) and GAD-7 (Cohen´s d =-0.85, 95% CI=-1.07 to -0.62, P<0.001) following TDM. The prevalence of mild depression dropped from 70.1% to 50.8% and moderate depression from 28.2% to 15.3%, while the prevalence of mild anxiety dropped from 54.8% to 38.4%, and moderate anxiety from 21.5% to 10.7% (all P<0.001). Rates of severe depression and anxiety did not drop significantly. Conclusion: The Daily Mile (TDM) might potentially reduce mild and moderate symptoms of anxiety and depression in school-going adolescents in low-income countries such as Uganda. For more severe cases, additional support is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.